Table 3.
Systemic Lupus Erythematosus (SLE) N = 3,500 |
Lupus Nephritis (LN) N = 1,297 |
|||
---|---|---|---|---|
| ||||
IR | IRR (95% CI) | IR | IRR (95% CI) | |
| ||||
Age | ||||
5 – <9 years | 7.9111.39 | ref | 15.95 | ref |
9 – <12 years | 10.00 | 1.44 (1.03, 2.02) | 19.36 | 1.21 (0.75, 1.96) |
12 – <15 years | 10.70 | 1.26 (0.92, 1.75) | 17.03 | 1.07 (0.68, 1.68) |
15 – <18 years | 10.79 | 1.35 (0.99, 1.86) | 17.74 | 1.11 (0.71, 1.73) |
| ||||
Sex | ||||
Female | 8.50 | ref | 18.69 | ref |
Male | 6.86 | 0.79 (0.66, 0.95) | 12.76 | 0.68 (0.52, 0.90) |
| ||||
Race/Ethnicity a | ||||
White | ref | 12.01 | ref | |
African American | 12.56 | 1.83 (1.51, 2.22) | 20.52 | 1.71 (1.23, 2.36) |
Asian | 6.86 | 1.00 (0.73, 1.37) | 11.00 | 0.92 (0.58, 1.45) |
Native American | 12.39 | 1.81 (1.17, 2.80) | 17.00 | 1.42 (0.72, 2.77) |
Hispanic | 9.46 | 1.38 (1.11, 1.71) | 17.27 | 1.44 (1.01, 2.04) |
| ||||
Region of residence | ||||
NorthEast | 9.47 | ref | 17.90 | ref |
South | 11.09 | 1.17 (0.98, 1.40) | 19.07 | 1.07 (0.84, 1.36) |
West | 8.77 | 0.93 (0.76, 1.13) | 13.85 | 0.77 (0.58, 1.03) |
MidWest | 12.42 | 1.31 (1.07, 1.61) | 20.19 | 1.13 (0.84, 1.52) |
| ||||
SLE Risk Adjustment Index b | ||||
Low | 7.11 | ref | 14.20 | ref |
High | 15.68 | 2.21 (1.95, 2.50) | 28.26 | 1.99 (1.66, 2.39) |
| ||||
Socioeconomic status c | ||||
High | 10.70 | ref | 17.29 | ref |
Low | 10.12 | 0.95 (0.83, 1.07) | 17.99 | 0.96 (0.80, 1.15) |
| ||||
Preventive care use d | ||||
Prophylaxis | 13.78 | 1.39 (1.16, 1.65) | 21.62 | 1.28 (1.02,1.61) |
Influenza vaccination | 9.44 | 0.92 (0.58, 1.48) | 19.28 | 1.07 (0.60, 1.88) |
Pneumococcal vaccination | 3.95 | 0.37 (0.11, 1.19) | — | — |
Incidence rates (IR) are reported per 100 person years (PY).
Bolded IRRs indicated statistically significant (p<0.05) values
4.7% of children with SLE had missing or other race reported
SLE Risk Adjustment index (median value in cohort is threshold for high vs. low)(17)
Socioeconomic status based on 7 zip-code level indicators from 2000 U.S. Census ((Z-scored, range −3.82 [lowest] to 6.06 [highest])(16)
Preventive care during the 6 month baseline period
— Cell counts of 10 or fewer individuals have been suppressed due to Federal reporting requirements.